“Study of Safety and Effect of T-AYU-HM Premium in Sickle Cell Anemia Patient: A Case Study”, Int J Ayu Pharm Res, vol. 10, no. 8, pp. 104–108, Sep. 2022, doi: 10.47070/ijapr.v10i8.2498.